POMBACE chemotherapy in non-seminomatous germ cell tumours: Outcome and importance of dose intensity
- 31 January 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (1) , 86-91
- https://doi.org/10.1016/0959-8049(92)90392-f
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosisBritish Journal of Cancer, 1989
- Germ cell tumour chemotherapyBritish Journal of Cancer, 1989
- Chemotherapy for Poor Risk Germ Cell Tumours An Independent Evaluation of the POM B/ACE RegimeBritish Journal of Urology, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.Journal of Clinical Oncology, 1986
- Current Optimum Management of Anaplastic Germ Cell Tumours of the Testis and Other SitesBritish Journal of Urology, 1986
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- Chemotherapy of advanced malignant teratomasBritish Journal of Cancer, 1980
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977